Meramec Financial Planners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$923K Buy
771
+631
+451% +$645K 0.34% 47
2026
Q1
$129K Buy
140
+24
+21% +$24.3K 0.05% 142
2025
Q4
$123K Buy
+116
New +$111K 0.05% 153

Other funds holding LLY

Meramec Financial Planners's LLY Position: Q2 2026 in Review

Meramec Financial Planners increased its Eli Lilly (LLY) stake by 451% in Q2 2026, buying an estimated $645K and bringing the position to 771 shares worth $923K. The position accounts for 0.34% of the portfolio, ranked #47.

Meramec Financial Planners first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,607 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Meramec Financial Planners held 771 shares of Eli Lilly worth $923K as of Q2 2026.
  • Meramec Financial Planners bought 631 Eli Lilly shares in Q2 2026, an estimated $645K.
  • Eli Lilly made up 0.34% of Meramec Financial Planners's portfolio in Q2 2026, its #47 holding.
  • Meramec Financial Planners first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,607 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Meramec Financial Planners's 13F filing for Q2 2026, filed 29 Jul 2026.